By Richard Sima The Washington Post Five years since the pandemic began, millions of people are still grappling with long COVID, even as new patients are joining their ranks. “Considering […]
Long COVID Now: A Special Report
Five years after the pandemic hit, questions remain about how and why millions of Americans are still struggling with long-term disease. Michele G. Sullivan, Health Central According to a June 2024 […]
Ivermectin, Hydroxychloroquine Use Soared During COVID-19 Pandemic, Study Says
Authored by Jack Phillips via The Epoch Times Ivermectin and hydroxychloroquine prescriptions “soared far above” levels before the COVID-19 pandemic, according to a new study. Researchers from the University of California […]
Extending Paxlovid Not Effective Against Long COVID
Friday, 07 June 2024 Newsmax Health An extended course of the antiviral drug Paxlovid won’t ease a person’s long COVID symptoms, a new study finds. People who took Paxlovid for […]
Treating COVID in a Shifting Landscape
SARS-CoV-2 keeps changing. What does this mean for the treatment of COVID-19? By EKATERINA PESHEVA January 3, 2023 Research Harvard As the world enters year four of the COVID-19 pandemic, scientists have […]
Paxlovid Rebound More Common Than Believed
However, the drug remains one of the most effective ways of preventing serious illness and death Published 11/14/23, Sarah Braner The Messenger Viral rebound after taking Paxlovid may be more common than […]
Long COVID: The hunt for causes and cures
With so many treatment candidates, researchers work to gain more clarity by Shi En Kim September 11, 2023 | A version of this story appeared in Volume 101, Issue 30 Hannah Davis […]
Paxlovid Is Now Less Effective Against Covid, Study Shows
Story by Nacha Cattan Sept 21, 2023 Bloomberg A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data […]
First long COVID treatment clinical trials from NIH getting underway
Alex Tan August 23, 2023 Two new clinical trials to test potential treatments for long COVID are now set to launch, the National Institutes of Health said Monday, opening enrollment for the […]
You’re MORE likely to get Covid again within weeks if you take Pfizer’s Paxlovid drug, early study indicates
Authors: MANSUR SHAHEEN DEPUTY HEALTH EDITOR FOR DAILYMAIL.COM PUBLISHED: 12:32 EST, 17 November 2022 People appear to be more likely to suffer a Covid rebound if they use Pfizer‘s antiviral drug Paxlovid, […]